IL143795A0 - Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections - Google Patents

Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections

Info

Publication number
IL143795A0
IL143795A0 IL14379500A IL14379500A IL143795A0 IL 143795 A0 IL143795 A0 IL 143795A0 IL 14379500 A IL14379500 A IL 14379500A IL 14379500 A IL14379500 A IL 14379500A IL 143795 A0 IL143795 A0 IL 143795A0
Authority
IL
Israel
Prior art keywords
hydroxylamic
isoxazolidinones
infections
acids
treatment
Prior art date
Application number
IL14379500A
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19903666A external-priority patent/DE19903666A1/en
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of IL143795A0 publication Critical patent/IL143795A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL14379500A 1999-01-13 2000-01-12 Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections IL143795A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19900907 1999-01-13
DE19903666A DE19903666A1 (en) 1999-01-13 1999-01-30 Medicines containing 3-isoxazolidinones and hydroxylamic acids as an active ingredient and their use
PCT/EP2000/000165 WO2000041473A2 (en) 1999-01-13 2000-01-12 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections

Publications (1)

Publication Number Publication Date
IL143795A0 true IL143795A0 (en) 2002-04-21

Family

ID=26051290

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14379500A IL143795A0 (en) 1999-01-13 2000-01-12 Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections

Country Status (14)

Country Link
EP (1) EP1143941A3 (en)
JP (1) JP2002534440A (en)
CN (1) CN1342078A (en)
AU (1) AU2436600A (en)
BR (1) BR0007491A (en)
CA (1) CA2360366A1 (en)
CZ (1) CZ20012380A3 (en)
HU (1) HUP0105412A2 (en)
IL (1) IL143795A0 (en)
NO (1) NO20013464L (en)
PL (1) PL350128A1 (en)
SK (1) SK9502001A3 (en)
TR (1) TR200102019T2 (en)
WO (1) WO2000041473A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035073A1 (en) 2001-10-25 2003-05-01 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
GB202209172D0 (en) * 2022-06-22 2022-08-10 Syngenta Crop Protection Ag Improvements in or relating to organic compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45174A (en) * 1973-08-10 1976-12-31 Merck & Co Inc Antibacterial compositions containing 3-fluoro-d-alanine type compound and n-substituted cycloserine compound
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2290442A1 (en) * 1974-11-06 1976-06-04 Aries Robert Cycloserine-(hexahydro)rifamycin SV condensates - antibiotics, prepd from 3-formyl rifamycins and opt N-alkylated cycloserine
EP0219923B1 (en) * 1985-04-30 1992-09-02 Takeda Chemical Industries, Ltd. Antibiotic derivatives, their production and use
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
JPS63119476A (en) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd Isoxazolidone derivative
JPS63119462A (en) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd 5-membered-ring n-sulfo compound
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
CA2158352A1 (en) * 1993-03-16 1994-09-29 Michael John Crimmin Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1995006031A1 (en) * 1993-08-23 1995-03-02 Immunex Corporation Inhibitors of tnf-alpha secretion
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1996013263A2 (en) * 1994-11-01 1996-05-09 Research Corporation Technologies, Inc. Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
US5919790A (en) * 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
WO1998043959A1 (en) * 1997-03-28 1998-10-08 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds

Also Published As

Publication number Publication date
HUP0105412A2 (en) 2002-05-29
EP1143941A2 (en) 2001-10-17
CA2360366A1 (en) 2000-07-20
NO20013464L (en) 2001-09-12
EP1143941A3 (en) 2002-02-06
AU2436600A (en) 2000-08-01
NO20013464D0 (en) 2001-07-12
CZ20012380A3 (en) 2002-01-16
PL350128A1 (en) 2002-11-04
TR200102019T2 (en) 2002-04-22
BR0007491A (en) 2001-11-20
JP2002534440A (en) 2002-10-15
WO2000041473A2 (en) 2000-07-20
SK9502001A3 (en) 2002-05-09
WO2000041473A3 (en) 2001-11-29
CN1342078A (en) 2002-03-27

Similar Documents

Publication Publication Date Title
EP1283702A4 (en) Medical dressing assembly and associated method of using the same
IL196301A0 (en) Medicament for the treatment of hapatitis c
PL344535A1 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
HUP0200738A3 (en) Method of the treatment of incontinence
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2073502A (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NZ513686A (en) Treatment of trauma
HUP0105310A2 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
AU1646201A (en) Pharmaceutical agent for the treatment of cachexia and/or cardiogenic shock
AU2566201A (en) Compounds and methods for the treatment of pain
AU2420101A (en) Method and composition for the treatment of pain
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
HUP0300043A3 (en) Method and composition for the treatment of pain
GB9904252D0 (en) Composition for the treatment of pain
IL150208A0 (en) Compound and method for the treatment of pain
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
HK1055288A1 (en) Novel aqueous composition and use of the same
AU2420201A (en) Compounds and methods for the treatment of pain
GB9603657D0 (en) Improvements in the treatment of vaginal infections
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.